These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32308772)

  • 21. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.
    Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Narita Y; Shibui S; Kayama T; Kitanaka C
    Stem Cell Res; 2014 Jan; 12(1):119-31. PubMed ID: 24185179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting CXCR4 to suppress glioma-initiating cells and chemoresistance in glioma.
    Wu Y; Hu Y; Tang L; Yin S; Lv L; Zhou P
    Cell Biol Int; 2022 Sep; 46(9):1519-1529. PubMed ID: 35731168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition.
    Liu T; Li A; Xu Y; Xin Y
    Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain.
    He D; Chen H; Muramatsu H; Lasek AW
    J Neurochem; 2015 Nov; 135(3):508-21. PubMed ID: 26206265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.
    Jiang Y; Boije M; Westermark B; Uhrbom L
    Neoplasia; 2011 Jun; 13(6):492-503. PubMed ID: 21677873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromatin Remodeling Factor BRG1 Regulates Stemness and Chemosensitivity of Glioma Initiating Cells.
    Ganguly D; Sims M; Cai C; Fan M; Pfeffer LM
    Stem Cells; 2018 Dec; 36(12):1804-1815. PubMed ID: 30171737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.
    Jeon HM; Kim SH; Jin X; Park JB; Kim SH; Joshi K; Nakano I; Kim H
    Cancer Res; 2014 Aug; 74(16):4482-92. PubMed ID: 24962027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.
    Garros-Regulez L; Aldaz P; Arrizabalaga O; Moncho-Amor V; Carrasco-Garcia E; Manterola L; Moreno-Cugnon L; Barrena C; Villanua J; Ruiz I; Pollard S; Lovell-Badge R; Sampron N; Garcia I; Matheu A
    Expert Opin Ther Targets; 2016; 20(4):393-405. PubMed ID: 26878385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
    Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
    Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death.
    Lorente M; Torres S; Salazar M; Carracedo A; Hernández-Tiedra S; Rodríguez-Fornés F; García-Taboada E; Meléndez B; Mollejo M; Campos-Martín Y; Barcia JA; Guzmán M; Velasco G
    Autophagy; 2011 Sep; 7(9):1071-3. PubMed ID: 21593591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation.
    Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C
    Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse induced glioma-initiating cell models and therapeutic targets.
    Kondo T
    Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective calcium sensitivity in immature glioma cancer stem cells.
    Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
    PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling.
    Hai L; Liu P; Yu S; Yi L; Tao Z; Zhang C; Abeysekera IR; Li T; Tong L; Ma H; Liu B; Xie Y; Zhou X; Lin Y; Zhu M; Zhang K; Ren B; Ming H; Huang Y; Yang X
    Cell Physiol Biochem; 2018; 51(6):2925-2937. PubMed ID: 30580328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.